Toxicity as a result of immunostimulation by biologics.

Toxicity as a result of immunostimulation by biologics.

Item
http://www.wikidata.org/entity/Q36788414
Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines.Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.A comparative analysis of acute-phase proteins as inflammatory biomarkers in preclinical toxicology studies: implications for preclinical to clinical translation.Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies.HIV type-1 latency: targeted induction of proviral reservoirs.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.Adverse consequences of immunostimulation.Regulatory forum opinion piece*: immunotoxicology assessments in nonhuman primates--challenges and opportunities.
P2860

Toxicity as a result of immunostimulation by biologics.

Item
http://www.wikidata.org/entity/Q36788414
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Toxicity as a result of immunostimulation by biologics.
@en
type
label
Toxicity as a result of immunostimulation by biologics.
@en
prefLabel
Toxicity as a result of immunostimulation by biologics.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Toxicity as a result of immunostimulation by biologics.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698